SEC Form 4 · accession 0001171843-17-005276
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia L Goldenberg
Director
Period of report
Aug 24, 2017
Accepted (ET)
Aug 28, 2017 · 8:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 24, 2017 | S | 25,000 | $10.2442 | D | 813,219 | D | |
| Common StockF3 | Aug 28, 2017 | S | 5,000 | $11.45 | D | 808,219 | D | |
| Common StockF2,F4,F3 | Aug 28, 2017 | S | 10,000 | $11.5591 | D | 798,219 | D | |
| Common StockF5 | holding | — | — | — | 5,128,014 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in column 4 is a weighted average price. The prices actually received in this transaction range from $10.15 to $10.31.
- F2The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- F3Includes a total of 635,935 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, a director of the issuer and the Issuer's Chief Scientific Officer and Chief Patent Officer.
- F4The price in column 4 is a weighted average price. The prices actually received in this transaction range from $11.55 to $11.59.
- F5Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.